Chemical inducers and transcriptional markers of oligodendrocyte differentiation

Journal of Neuroscience Research

Volumn 88, Issue 12, 2010, Pages 2546-2557

  Joubert, Lara ^a   Foucault, Isabelle ^a   Sagot, Yves ^a   Bernasconi, Lilia ^a,b   Duval, François ^a   Alliod, Chantal ^a   Frossard, Marie José ^a   Gobert, Rosanna Pescini ^a   Curchod, Marie Laure ^a   Salvat, Catherine ^a   Nichols, Anthony ^a   Pouly, Sandrine ^a   Rommel, Christian ^a,c   Roach, Arthur ^a   Van Huijsduijnen, Rob Hooft ^a  

^a MERCK SERONO S A   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Intellikine Inc   (United States)

Author keywords

cAMP; ErbB2; Myelin basic protein

Indexed keywords

BIOLOGICAL MARKER; BUDESONIDE; CYCLIC AMP; DEXAMETHASONE; ENZYME ACTIVATOR; FLUNISOLIDE; FORSKOLIN; GLUCOCORTICOID; HORMONE RECEPTOR; HYDROCORTISONE; LAPATINIB; LEFLUNOMIDE; NUCLEOSIDE DERIVATIVE; PD 174265; PROTEIN INHIBITOR; RETINOIC ACID; RIBAVIRIN; TERIFLUNOMIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN CORTEX; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; LIBRARY; LYMPHOMA; MULTIPLE SCLEROSIS; NERVE CELL CULTURE; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAINING; STEM CELL; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIC AMP; FORSKOLIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OLIGODENDROGLIA; RATS; RECEPTOR, ERBB-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 77955477588     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22434     Document Type: Article

References (40)

1. Aston C, Jiang L, Sokolov BP. 2005. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10:309-322. (Pubitemid 40432684)
2. Bartzokis G. 2009. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging (in press).
3. Bhalla K, Luo Y, Buchan T, Beachem MA, Guzauskas GF, Ladd S, Bratcher SJ, Schroer RJ, Balsamo J, DuPont BR, Lilien J, Srivastava AK. 2008. Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability. Am J Hum Genet 83:703-713.
4. Cockerill S, Stubberfield C, Stables J, Carter M, Guntrip S, Smith K, McKeown S, Shaw R, Topley P, Thomsen L, Affleck K, Jowett A, Hayes D, Willson M, Woollard P, Spalding D. 2001. Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and CerbB-2. Bioorg Med Chem Lett 11:1401-1405.
5. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26:10967-10983.
6. Esmailpour N, Hogger P, Rohdewald P. 1998. Binding kinetics of budesonide to the human glucocorticoid receptor. Eur J Pharm Sci 6:219-223.
7. Fields RD. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31:361-370.
8. Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Strand V, Kirschbaum BJ. 1999. Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 93:198-208.
9. Franco PG, Silvestroff L, Soto EF, Pasquini JM. 2008. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination. Exp Neurol 212:458-467.
10. Franklin RJ, Kotter MR. 2008. The biology of CNS remyelination: the key to therapeutic advances. J Neurol 255(Suppl 1):19-25.
11. Fry DW, Bridges AJ, Denny WA, Doherty A, Greis KD, Hicks JL, Hook KE, Keller PR, Leopold WR, Loo JA, McNamara DJ, Nelson JM, Sherwood V, Smaill JB, Trumpp-Kallmeyer S, Dobrusin EM. 1998. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc Natl Acad Sci U S A 95:12022-12027. (Pubitemid 28460532)
12. Gadea A, Aguirre A, Haydar TF, Gallo V. 2009. Endothelin-1 regulates oligodendrocyte development. J Neurosci 29:10047-10062.
13. Hudson LD. 2003. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene. J Child Neurol 18:616-624.
14. Jung M, Kramer E, Grzenkowski M, Tang K, Blakemore W, Aguzzi A, Khazaie K, Chlichlia K, von Blankenfeld G, Kettenmann H, et al. 1995. Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci 7:1245-1265.
15. Kim JY, Sun Q, Oglesbee M, Yoon SO. 2003. The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo. J Neurosci 23:5561-5571.
16. Kippert A, Trajkovic K, Fitzner D, Opitz L, Simons M. 2008. Identification of Tmem10/Opalin as a novel marker for oligodendrocytes using gene expression profiling. BMC Neurosci 9:40.
17. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749-1758.
18. Lavrnja I, Stojkov D, Bjelobaba I, Pekovic S, Dacic S, Nedeljkovic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Rakic L, Stojiljkovic M. 2008. Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production. Int Immunopharmacol 8:1282-1290.
19. Li H, He Y, Richardson WD, Casaccia P. 2009. Two-tier transcriptional control of oligodendrocyte differentiation. Curr Opin Neurobiol 19:479-485.
20. Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM. 1996. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 10:934-947.
21. Liu Z, Hu X, Cai J, Liu B, Peng X, Wegner M, Qiu M. 2007. Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol 302:683-693.
22. Lubetzki C, Demerens C, Anglade P, Villarroya H, Frankfurter A, Lee VM, Zalc B. 1993. Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci U S A 90:6820-6824.
23. McMorris FA. 1983. Cyclic AMP induction of the myelin enzyme 2′,3′-cyclic nucleotide 3′-phosphohydrolase in rat oligodendrocytes. J Neurochem 41:506-515.
24. Mirsky R, Stewart HJ, Tabernero A, Bradke F, Brennan A, Dong Z, Jessen KR. 1996. Development and differentiation of Schwann cells. Rev Neurol 152:308-313.
25. Namkoong S, Kim CK, Cho YL, Kim JH, Lee H, Ha KS, Choe J, Kim PH, Won MH, Kwon YG, Shim EB, Kim YM. 2009. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell Signal (in press).
26. Noll E, Miller RH. 1994. Regulation of oligodendrocyte differentiation: a role for retinoic acid in the spinal cord. Development 120:649-660. (Pubitemid 24071206)
27. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343:938-952.
28. Palacios N, Sanchez-Franco F, Fernandez M, Sanchez I, Villuendas G, Cacicedo L. 2007. Opposite effects of two PKA inhibitors on cAMP inhibition of IGF-I-induced oligodendrocyte development: a problem of unspecificity? Brain Res 1178:1-11.
29. Pescini Gobert R, Joubert L, Curchod M-L, Salvat C, Foucault I, Jorand-Lebrun C, Lamarine M, Peixoto H, Vignaud C, Frémaux C, Jomotte T, Françon B, Alliod C, Bernasconi L, Abderrahim H, Perrin D, Bombrun A, Zanoguera F, Rommel C, Hooft van Huijsduijnen R. 2009. Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol 29:1538-1553.
30. Richter-Landsberg C. 2008. Oligodendrocytes take center stage. Introduction. J Mol Neurosci 35:1-2.
31. Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Van Evercooren AB, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U. 2004. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci 25:707-721.
32. Sobue G, Pleasure D. 1984. Schwann cell galactocerebroside induced by derivatives of adenosine 30,50-monophosphate. Science 224:72-74. (Pubitemid 14127204)
33. Stadelmann C, Bruck W. 2008. Interplay between mechanisms of damage and repair in multiple sclerosis. J Neurol 255(Suppl 1):12-18.
34. Talbott JF, Cao Q, Bertram J, Nkansah M, Benton RL, Lavik E, Whittemore SR. 2007. CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Exp Neurol 204:485-489.
35. Tapinos N, Ohnishi M, Rambukkana A. 2006. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med 12:961-966. (Pubitemid 44175150)
36. Vartanian T, Goodearl A, Viehover A, Fischbach G. 1997. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J Cell Biol 137:211-220.
37. Vartanian T, Fischbach G, Miller R. 1999. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci U S A 96:731-735. (Pubitemid 29061277)
38. Wegner M. 2008. A matter of identity: transcriptional control in oligodendrocytes. J Mol Neurosci 35:3-12.
39. Wust S, van den Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Luhder F, Reichardt HM. 2008. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 180:8434-8443.
40. Yoon C, Korade Z, Carter BD. 2008. Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype. J Neurosci 28:3738-3746.